REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Vancsura Istvan ec. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DR. VANCSURA ISTVAN EGYENI CEG Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Dr. Vancsura Istvan ec. is an enterprise in Hungary, with the main office in Tiszaalpar. The company operates in the Pharmacies and Drug Stores industry. It was incorporated on December 31, 2009. It currently has a total number of 4 (2023) employees. From the latest financial highlights, Dr. Vancsura Istvan ec. reported a net sales revenue increase of 6.21% in 2022. Its’ total assets recorded a growth of 10.35%. Dr. Vancsura Istvan ec.’s net profit margin decreased by 1.04% in 2022.

Headquarters
Matyas kiraly utca 1.
Tiszaalpar; Bacs-Kiskun; Postal Code: 6066

Contact Details: Purchase the Dr. Vancsura Istvan ec. report to view the information.

Website: http://www.cerasus.t-online.hu

Basic Information
Total Employees:
Purchase the Dr. Vancsura Istvan ec. report to view the information.
Outstanding Shares:
Purchase the Dr. Vancsura Istvan ec. report to view the information.
Registered Capital:
Purchase the Dr. Vancsura Istvan ec. report to view the information.
Incorporation Date:
December 31, 2009
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Csanad Pharma Kft.
Company Performance
Financial values in the chart are available after Dr. Vancsura Istvan ec. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.21%
Total operating revenue
6.77%
Operating profit (EBIT)
-10.49%
EBITDA
-10.37%
Net Profit (Loss) for the Period
-15.14%
Total assets
10.35%
Total equity
5.16%
Operating Profit Margin (ROS)
-0.9%
Net Profit Margin
-1.04%
Return on Equity (ROE)
-1.18%
Quick Ratio
-6.41%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?